arrow
A

Azita H. Talasaz

virginia commonwealth university
H指数:28
被引数:3,135

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Coated or chewable aspirin and a hybrid air pollution mitigation strategy in patients with atherosclerotic disease: rationale and design of the COATED-AIR randomized trial

包衣或咀嚼型阿司匹林及一种混合空气污染缓解策略在动脉粥样硬化患者中的应用:COATED-AIR随机试验的原理与设计

2026-09-230
OAAI
Fibrinolytic Therapy for Thromboembolic Diseases

血栓栓塞性疾病溶栓治疗

JACC
IF0
2025-09-290
PRE
Safety and effectiveness of statins in hospitalized patients with COVID-19: Systematic review and collaborative meta-analysis of randomized controlled trials

他汀类药物在COVID-19住院患者中的安全性与有效性:随机对照试验的系统评价和协作性Meta分析

2025-09-200
PRE
Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications

血栓栓塞性疾病中的纤维蛋白溶解剂: 历史观点和批准的适应症

2024-03-016
PRE
Impact of C-reactive protein levels and role of anakinra in patients with ST-elevation myocardial infarction

急性心肌梗死患者C反应蛋白水平的影响及anakinra的作用

2024-03-017
OAAI
Differential Response to Interleukin-1 Blockade With Anakinra on Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction Stratified According to Left Ventricular Ejection Fraction
2023-09-192
OAAI
Comparison of Safety and Biological Efficacy of Anakinra (Kineret) Dispensed in Polycarbonate Plastic versus Borosilicate Glass Syringes: A Patient-Level Analysis of VCUART2 and VCUART3 Clinical Trials
2023-08-012
OAAI